5-137617888-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_017415.3(KLHL3):c.*4210A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.654 in 152,034 control chromosomes in the GnomAD database, including 32,833 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.65 ( 32801 hom., cov: 31)
Exomes 𝑓: 0.70 ( 32 hom. )
Consequence
KLHL3
NM_017415.3 3_prime_UTR
NM_017415.3 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.06
Genes affected
KLHL3 (HGNC:6354): (kelch like family member 3) This gene is ubiquitously expressed and encodes a full-length protein which has an N-terminal BTB domain followed by a BACK domain and six kelch-like repeats in the C-terminus. These kelch-like repeats promote substrate ubiquitination of bound proteins via interaction of the BTB domain with the CUL3 (cullin 3) component of a cullin-RING E3 ubiquitin ligase (CRL) complex. Muatations in this gene cause pseudohypoaldosteronism type IID (PHA2D); a rare Mendelian syndrome featuring hypertension, hyperkalaemia and metabolic acidosis. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Mar 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BP6
Variant 5-137617888-T-C is Benign according to our data. Variant chr5-137617888-T-C is described in ClinVar as [Benign]. Clinvar id is 350923.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.699 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KLHL3 | NM_017415.3 | c.*4210A>G | 3_prime_UTR_variant | 15/15 | ENST00000309755.9 | NP_059111.2 | ||
KLHL3 | NM_001257194.1 | c.*4210A>G | 3_prime_UTR_variant | 15/15 | NP_001244123.1 | |||
KLHL3 | NM_001257195.2 | c.*4210A>G | 3_prime_UTR_variant | 13/13 | NP_001244124.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KLHL3 | ENST00000309755.9 | c.*4210A>G | 3_prime_UTR_variant | 15/15 | 1 | NM_017415.3 | ENSP00000312397 | P1 | ||
KLHL3 | ENST00000506491.5 | c.*4210A>G | 3_prime_UTR_variant | 13/13 | 1 | ENSP00000424828 | ||||
KLHL3 | ENST00000508657.5 | c.*4210A>G | 3_prime_UTR_variant | 15/15 | 1 | ENSP00000422099 | ||||
KLHL3 | ENST00000509694.1 | n.623-24A>G | intron_variant, non_coding_transcript_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.654 AC: 99336AN: 151800Hom.: 32789 Cov.: 31
GnomAD3 genomes
AF:
AC:
99336
AN:
151800
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.698 AC: 81AN: 116Hom.: 32 Cov.: 0 AF XY: 0.727 AC XY: 48AN XY: 66
GnomAD4 exome
AF:
AC:
81
AN:
116
Hom.:
Cov.:
0
AF XY:
AC XY:
48
AN XY:
66
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.654 AC: 99392AN: 151918Hom.: 32801 Cov.: 31 AF XY: 0.659 AC XY: 48927AN XY: 74270
GnomAD4 genome
AF:
AC:
99392
AN:
151918
Hom.:
Cov.:
31
AF XY:
AC XY:
48927
AN XY:
74270
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Autosomal dominant pseudohypoaldosteronism type 1 Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Pseudohypoaldosteronism type 2D Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 12, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at